Particle News: Latest Sanofi news

Zeus, the Mechanical Horse of Paris 2024 Olympics, Embarks on Nationwide Tour

The iconic metallic horse from the Paris 2024 Olympic opening ceremony will travel across France and Europe, showcasing art, technology, and science.

4 ARTICLES

5mo ago

Sanofi and J&J Halt E. coli Vaccine Trial After Insufficient Efficacy

3 ARTICLES

6mo ago

Minnesota Secures $35 Monthly Insulin Cap in Landmark Settlement with Novo Nordisk

3 ARTICLES

2mo ago

Novavax Reports Narrower Q4 Loss and Strategic Shift Away from COVID-19 Vaccine Commercialization

5 ARTICLES

2mo ago

FDA Warns of Rare Severe Itching After Stopping Common Allergy Medications

4 ARTICLES

3mo ago

German Pharma Sector Projects Growth While Warning of Potential US Tariff Impacts

5 ARTICLES

3mo ago

Pharma CEOs Urge EU to Reform Pricing Policies as U.S. Investments Surge

6 ARTICLES

2w ago

Sanofi Signs $1.15 Billion Deal to Acquire Vicebio’s Molecular Clamp Respiratory Vaccine Platform

6 ARTICLES

3d ago

U.S. Cancels 22 mRNA Vaccine Contracts, Shifts Funding to Broader Platforms

3 ARTICLES

2mo ago

FDA Approves Merck’s Enflonsia Monoclonal Antibody for Infant RSV Prevention

3 ARTICLES

last mo.

CDC Panel Recommends Merck’s Enflonsia Monoclonal Antibody for Babies

3 ARTICLES

last mo.

FDA Approves Regeneron and Sanofi’s Dupixent for Bullous Pemphigoid

4 ARTICLES

2mo ago

Mixed Phase 3 Outcomes Cloud Future of Regeneron and Sanofi’s COPD Candidate Itepekimab

3 ARTICLES

5mo ago

Sanofi Indicted Over Toxic Emissions at Mourenx Plant

Particle.news

Sanofi

Pharmaceutical industry company

Zeus, the Mechanical Horse of Paris 2024 Olympics, Embarks on Nationwide Tour

Sanofi and J&J Halt E. coli Vaccine Trial After Insufficient Efficacy

Minnesota Secures $35 Monthly Insulin Cap in Landmark Settlement with Novo Nordisk

Sanofi Announces $20 Billion U.S. Investment to Expand Manufacturing and R&D

Sanofi Secures $1.9 Billion Deal for Dren Bio’s Innovative Autoimmune Therapy

UK Faces Three-Week Shortage of Yellow Fever Vaccine

FDA Grants Limited Approval to Novavax’s COVID-19 Vaccine

Sanofi’s $20 Billion US Investment Draws Criticism in France

Sanofi Employees Protest Planned Sale of Amilly Factory

Novavax Reports Narrower Q4 Loss and Strategic Shift Away from COVID-19 Vaccine Commercialization

Never miss stories about

Sanofi

FDA Warns of Rare Severe Itching After Stopping Common Allergy Medications

German Pharma Sector Projects Growth While Warning of Potential US Tariff Impacts

Pharma CEOs Urge EU to Reform Pricing Policies as U.S. Investments Surge

Sanofi Signs $1.15 Billion Deal to Acquire Vicebio’s Molecular Clamp Respiratory Vaccine Platform

U.S. Cancels 22 mRNA Vaccine Contracts, Shifts Funding to Broader Platforms

FDA Approves Merck’s Enflonsia Monoclonal Antibody for Infant RSV Prevention

CDC Panel Recommends Merck’s Enflonsia Monoclonal Antibody for Babies

FDA Approves Regeneron and Sanofi’s Dupixent for Bullous Pemphigoid

Mixed Phase 3 Outcomes Cloud Future of Regeneron and Sanofi’s COPD Candidate Itepekimab

Sanofi Indicted Over Toxic Emissions at Mourenx Plant

Never miss stories about

Sanofi